Log in to save to my catalogue

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2739465073

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a phase 2 trial, bepirovirsen, an antisense oligonucleotide that targets all hepatitis B virus mRNAs, resulted in sustained loss of hepatitis B surface antigen and HBV DNA in 9 to 10% of participants with chronic HBV infection.

Alternative Titles

Full title

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2739465073

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2739465073

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2210027

How to access this item